XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share capital and reserves (Details)

Share capital and reserves (Details)					12 Months Ended
Share capital and reserves (Details)	Oct. 07, 2022 CAD ($)	Oct. 07, 2022 $ / shares	Oct. 15, 2021 CAD ($)	Feb. 09, 2021 CAD ($)	Dec. 31, 2022 CAD ($) shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 CAD ($) shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 CAD ($)	Nov. 08, 2021 shares
Share capital and reserves
Average Remaining contractual life					4 years 3 months		4 years 7 months 6 days
Value of shares issued from exercise of warrants \| $					$ 87		$ 2,855,983
[custom:ExpectedLife]					5 years		5 years
Expected volatility	100.00%		100.00%	100.00%	100.00%		100.00%
Share-based payment expense \| $					$ 632,548		$ 499,158		$ 293,493
Number of warrants issued \| shares					15,030,687	15,030,687	12,989,687	12,989,687		3,261,000
Fair value of the warrants \| $	$ 254,684		$ 371,251	$ 150,000	$ 5,093,593		$ 5,358,000
Share price on date of grant \| $ / shares						$ 1.01		$ 3.64
expected life	5 years		5 years	5 years	5 years		5 years
Number of options exercised \| shares							640,012
Derivative warrant liability reclassified to share capital on exercise of warrants \| $							$ 425,900
Statutory reserve \| $			$ 4,460,000
Exercise price warrant \| $ / shares		$ 4.77				1.22		4.70
Risk free rate					3.66%		0.58%
Expected dividend yield					0.00%		0.00%
Warrant reserve [member]
Share capital and reserves
Average Remaining contractual life					4 years 1 month 24 days		4 years 6 months 21 days
Exercise price warrant \| $ / shares						1.17
Stock Options [Member]
Share capital and reserves
Average Remaining contractual life					3 years 5 months 4 days		3 years 5 months 1 day
Number of options exercised \| shares							(51,106)
Derivative Warrant Liabilities [Member]
Share capital and reserves
Average Remaining contractual life							4 years 9 months 18 days
Expected volatility					100.00%		100.00%
Share price on date of grant \| $ / shares						$ 0.81		$ 2.05
Risk free rate					3.55%		1.23%
Derivative Warrant Liabilities [Member] \| Bottom of range [member]
Share capital and reserves
Average Remaining contractual life					3 years 9 months 18 days
Derivative Warrant Liabilities [Member] \| Top of range [member]
Share capital and reserves
Average Remaining contractual life					4 years 9 months 18 days
Derivative Warrants Liabilities [Member]
Share capital and reserves
Number of warrants issued \| shares							2,085,687	2,085,687
Ifrs IPO [Member]
Share capital and reserves
Expected volatility							100.00%
Fair value of the warrants \| $							$ 7,425,000
Share price on date of grant \| $ / shares								$ 3.02
expected life							5 years
Exercise price warrant \| $ / shares								$ 4.77
Risk free rate							1.50%
Expected dividend yield							0.00%